Alkagesta has outlined its sustainable aviation fuel trading and delivery capabilities following its participation in the SAF Global Summit 2026 in London. In a report on its own website, the company highlighted fuel certification, access to EU ETS allowances and use of the NATO Central Europe Pipeline System as elements of its aviation fuels business.
The company said it holds ISCC and CORSIA certification, which enables it to trade and supply CORSIA-eligible sustainable aviation fuel across multiple sustainability jurisdictions. It also reported recently gaining access to EU ETS allowances. Alkagesta described that access as complementary to its SAF and biofuels trading activities, allowing it to support customers with a wider range of carbon compliance obligations alongside its fuel supply capabilities.
On logistics, Alkagesta said it secured access to the NATO Central Europe Pipeline System, known as CEPS, earlier in 2026. According to the company, this enables it to deliver jet fuel blended with sustainable aviation fuel directly to airlines. It presented the development as part of its expanding role in the aviation fuels market, alongside the certification and compliance capabilities outlined in its summit report.
Alkagesta was represented at the two-day event by Business Development Manager Alex Yusifli and Operations Manager Alasgar Guliyev. Its account said the gathering attracted more than 1,000 senior executives spanning the SAF value chain, including policymakers, energy executives, producers, investors, airlines and aircraft manufacturers. The programme focused on policy, investment, production and supply-chain logistics, together with new technologies.
The company placed its attendance within its broader biofuels and sustainable fuels strategy, describing SAF as an increasingly important commercial component. Alkagesta also said demand for certified sustainable aviation fuel was growing across European and global aviation markets, linking that trend to the relevance of its trading and supply activities.
Read the original announcement on Alkagesta.